Search Within

Zachary Drew Epstein-Peterson

Formats
  1. Meeting Abstract (56)
  2. Journal Article (21)
  3. Review (9)
  4. Research Letter (7)
  5. Editorial (1)
Groups
  1. Hematologic Malignancies, Division of (94)
  2. Hematology-Oncology Fellows (94)
  3. Department of Medicine (90)
  4. Center for Hematologic Malignancies (89)
  5. Lymphoma (69)
  6. Population Sciences Research Program (54)

More Groups

People
  1. Steven Horwitz (47)
  2. Alison Moskowitz (45)
  3. Anita Kumar (43)
  4. Gilles Salles (38)
  5. Maria Palomba (38)
  6. Andrew Zelenetz (35)

More People

Years
  1. 2025 (8)
  2. 2024 (23)
  3. 2023 (24)
  4. 2022 (10)
  5. 2021 (8)
  6. 2020 (7)

More Years

Publications
  1. Blood (49)
  2. Blood Advances (5)
  3. Haematologica (5)
  4. Hematological Oncology (4)
  5. Leukemia Research (4)
  6. American Journal of Hematology (3)

More Publications

Publishers
  1. American Society of Hematology (55)
  2. Wiley Blackwell (6)
  3. Ferrata Storti Foundation (5)
  4. Elsevier Ltd (4)
  5. Nature Publishing Group (4)
  6. John Wiley & Sons, Inc. (3)

More Publishers

Results (94)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Single-agent mosunetuzumab produces high complete response rates in patients with newly diagnosed follicular lymphoma: Primary analysis of the MITHIC-FL1 trial
    Meeting Abstract

    Falchi, L.; Okwali, M.; Ferreira Lopes, A.; Hamlin, P. A.; Lue, J. K.; Ghione, P.; Owens, C.; Torka, P.; Kumar, A.; Steiner, R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Tumor determinants of response to CAR-T therapy in relapsed or refractory mantle cell lymphoma
    Meeting Abstract

    Epstein-Peterson, Z. D.; Ryan, C. E.; Devlin, S. M.; Accav, N. G.; Avigdor, A.; Corona, M.; Danylesko, I.; Dela Cruz, J.; Goy, A.; Jacobson, C. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Treatment patterns and outcomes following progression of disease post-CAR-T therapy in relapsed or refractory mantle cell lymphoma: A multicenter analysis
    Meeting Abstract

    Epstein-Peterson, Z. D.; Lionel, A. C.; Joseph, A.; Drill, E.; Atallah-Yunes, S. A.; Brooks, T. R.; Chong, E. A.; Chong, E. R.; Dela Cruz, J.; Frank, M. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Characterization of skin response in patients with mycosis fungoides and sezary syndrome treated with mogamulizumab: A retrospective, real world cohort
    Meeting Abstract

    Christensen, R.; Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Horwitz, S.; Johnson, W. T.; Moskowitz, A.; Myskowski, P.; Pulitzer, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • T-cell-based therapies for treating relapsed or refractory mantle cell lymphoma
    Review

    Epstein-Peterson, Z. D.; Palomba, M. L.
    Hematology-American Society of Hematology Education Program (2024)

    Fulltext@MSK | Save
  • Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
    Research Letter

    Lue, J. K.; Luttwak, E.; Rivas-Delgado, A.; Irawan, H.; Boardman, A.; Caron, P. C.; David, K.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • What is high-risk mantle cell lymphoma, and how should we treat it?
    Journal Article

    Epstein-Peterson, Z.; Kumar, A.
    Targeted Therapies in Oncology (2024)

    Fulltext@MSK | Save
  • Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis
    Research Letter

    Johnson, W. T.; Epstein-Peterson, Z. D.; Ganesan, N.; Pak, T.; Chang, T.; Dao, P.; Moskowitz, A. J.; Stuver, R. N.; Ghione, P.; Galasso, N.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation
    Research Letter

    Stuver, R.; Mian, A.; Brown, S.; Devlin, S.; Caimi, P. F.; Chinapen, S.; Dahi, P.; Dean, R.; Epstein-Peterson, Z. D.; Hill, B.; more...
    American Journal of Hematology (2024)

    Fulltext@MSK | Save